home / stock / cntg / cntg news

CNTG News and Press, Centogene N.V. From 04/23/20

Stock Information
Company Name: Centogene N.V.
Stock Symbol: CNTG
Market: NASDAQ
Website: centogene.com
Menu
CNTG CNTG Quote CNTG Short CNTG News CNTG Articles CNTG Message Board
Get CNTG Alerts

News, Short Squeeze, Breakout and More Instantly...
CNTG - Centogene Reports Financial Results For Full Year 2019 and Highlights Recent Progress

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 23, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutica...
CNTG - CENTOGENE Releases a New Swab Product to Facilitate the Simple Diagnosis of COVID-19

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 21, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical co...

CNTG - CENTOGENE and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19

ROSTOCK, Germany and COLOGNE, Germany, April 17, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, an...

CNTG - CENTOGENE to Report Full Year 2019 Financial Results on April 23, 2020

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 16, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical co...
CNTG - CENTOGENE Announces Opening of Laboratory in Hamburg, Germany

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Germany, April 15, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmace...

CNTG - CENTOGENE Announces Commencement of Testing for COVID-19

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Germany, March 18, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceu...

CNTG - APRN, IBIO, MFA and CMO among midday movers

Gainers: Biomerica (NASDAQ: BMRA )  +288% . More news on: Biomerica, Inc., Blue Apron Holdings, Inc., ShiftPixy, Inc., Stocks on the move, , Read more ...

CNTG - CENTOGENE Announces Changes in Supervisory Board

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 17, 2020 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutic...

CNTG - CENTOGENE Announces Departure of Dirk Ehlers From Executive Board

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 09, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG) ─ The Company today announced that Dr. Dirk H. Ehlers, COO and President of its Clinical Diagnostics Division, has decided to step down from his role after the Annual Gener...

CNTG - CENTOGENE Marks Rare Disease Day 2020 With a Global Line up of Events

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 29, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical comp...
Previous 10 Next 10